 |
|
|
| |
Real-World Utilization of Cabotegravir +
Rilpivirine in the US: Data From Trio Health Cohort
|
| |
| |
CROI 2024 March 3-6 Denver
Joseph J. Eron1, Supriya Sarkar2, Andrew Frick3, Janna Radtchenko3, Gayathri Sridhar2, Leigh Ragone2, Karam Mounzer4, Steven Santiago5, Jean van Wyk6, Richard Elion3, Vani Vannappagari2
1University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, 2ViiV Healthcare, Durham, NC, USA, 3Trio Health, Louisville, CO, USA,
4School of Medicine at the University of Pennsylvania; Philadelphia Fight Community Health Centers, Philadelphia, PA, USA; 5Care Resource, Miami, FL, USA, 6ViiV Healthcare, London, UK
|
| |
|
|
|
|
|
